The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations

Mov Disord. 1999 May;14(3):517-9. doi: 10.1002/1531-8257(199905)14:3<517::aid-mds1025>3.0.co;2-u.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Antiparkinson Agents / adverse effects*
  • Dose-Response Relationship, Drug
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / drug therapy*
  • Dyskinesia, Drug-Induced / etiology*
  • Female
  • Humans
  • Levodopa / adverse effects*
  • Male
  • Middle Aged
  • N-Methylaspartate / antagonists & inhibitors*
  • Parkinson Disease / drug therapy*
  • Pilot Projects
  • Piperidines / pharmacology*
  • Piperidines / therapeutic use*
  • Severity of Illness Index

Substances

  • Antiparkinson Agents
  • Piperidines
  • Levodopa
  • N-Methylaspartate
  • budipine